Haruka Yamaguchi

1.7k total citations
46 papers, 1.5k citations indexed

About

Haruka Yamaguchi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Haruka Yamaguchi has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Haruka Yamaguchi's work include Lung Cancer Treatments and Mutations (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Alzheimer's disease research and treatments (6 papers). Haruka Yamaguchi is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Alzheimer's disease research and treatments (6 papers). Haruka Yamaguchi collaborates with scholars based in Japan, Australia and United States. Haruka Yamaguchi's co-authors include Kazuhiko Nakagawa, Isamu Okamoto, Kiyoko Kuwata, Kazuto Nishio, Ken Takezawa, Wataru Okamoto, Junko Tanizaki, Kazuko Sakai, Erina Hatashita and Junko Ishizeki and has published in prestigious journals such as Brain, Neurology and Water Research.

In The Last Decade

Haruka Yamaguchi

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruka Yamaguchi Japan 20 727 656 613 175 159 46 1.5k
Meghna Waghray United States 15 663 0.9× 299 0.5× 623 1.0× 229 1.3× 261 1.6× 15 1.4k
Géraldine Perkins France 17 651 0.9× 273 0.4× 529 0.9× 208 1.2× 458 2.9× 44 1.6k
Cristina Colarossi Italy 26 1.1k 1.5× 374 0.6× 604 1.0× 246 1.4× 461 2.9× 80 2.3k
Yanlin Yu United States 18 913 1.3× 194 0.3× 377 0.6× 107 0.6× 197 1.2× 35 1.5k
Marie‐José Terrier‐Lacombe France 23 681 0.9× 703 1.1× 439 0.7× 398 2.3× 218 1.4× 40 1.8k
T Tokunaga Japan 22 942 1.3× 300 0.5× 641 1.0× 216 1.2× 438 2.8× 36 1.6k
Caname Iwata Japan 17 942 1.3× 176 0.3× 797 1.3× 275 1.6× 215 1.4× 21 1.8k
Chohei Sakakura Japan 19 542 0.7× 326 0.5× 324 0.5× 525 3.0× 146 0.9× 63 1.4k
Sey‐En Lin Taiwan 18 400 0.6× 274 0.4× 327 0.5× 178 1.0× 175 1.1× 52 978
Patricia R. Segarini United States 22 1.7k 2.3× 161 0.2× 412 0.7× 155 0.9× 232 1.5× 28 2.4k

Countries citing papers authored by Haruka Yamaguchi

Since Specialization
Citations

This map shows the geographic impact of Haruka Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruka Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruka Yamaguchi more than expected).

Fields of papers citing papers by Haruka Yamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruka Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruka Yamaguchi. The network helps show where Haruka Yamaguchi may publish in the future.

Co-authorship network of co-authors of Haruka Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Haruka Yamaguchi. A scholar is included among the top collaborators of Haruka Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruka Yamaguchi. Haruka Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Haruka, et al.. (2024). Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer. International Journal of Molecular Sciences. 25(6). 3233–3233. 3 indexed citations
3.
Tsuchimochi, Makoto, Haruka Yamaguchi, Kazuhide Hayama, et al.. (2019). Imaging of Metastatic Cancer Cells in Sentinel Lymph Nodes using Affibody Probes and Possibility of a Theranostic Approach. International Journal of Molecular Sciences. 20(2). 427–427. 8 indexed citations
4.
Yamaguchi, Haruka, Namfon Pantarat, Takamasa Suzuki, & Andreas Evdokiou. (2019). Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer. International Journal of Molecular Sciences. 20(23). 5835–5835. 23 indexed citations
5.
Yamaguchi, Haruka, Kazuhide Hayama, Ichiro Sasagawa, et al.. (2018). HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells. International Journal of Molecular Sciences. 19(3). 908–908. 22 indexed citations
6.
Yamaguchi, Haruka, Makoto Tsuchimochi, Kazuhide Hayama, Tomoyuki Kawase, & Norio Tsubokawa. (2016). Dual-Labeled Near-Infrared/99mTc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells. International Journal of Molecular Sciences. 17(7). 1086–1086. 34 indexed citations
7.
Yoshida, Takeshi, Guolin Zhang, Matthew A. Smith, et al.. (2014). Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(15). 4059–4074. 89 indexed citations
9.
Okamoto, Wataru, Isamu Okamoto, Tokuzo Arao, et al.. (2012). Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification. Molecular Cancer Therapeutics. 11(7). 1557–1564. 73 indexed citations
10.
Tanizaki, Junko, Isamu Okamoto, Takafumi Okabe, et al.. (2012). Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(22). 6219–6226. 126 indexed citations
11.
Katayama, T., et al.. (2012). ANALYSIS ON INTERACTION BETWEEN RIVER AND GROUNDWATER IN KUROBE RIVER FAN BY A GRID-BASED HYDROLOGICAL MODEL. Journal of Japan Society of Civil Engineers Ser B1 (Hydraulic Engineering). 68(4). I_481–I_486. 2 indexed citations
12.
Tanizaki, Junko, Isamu Okamoto, Ken Takezawa, et al.. (2012). Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells. British Journal of Cancer. 106(4). 763–767. 47 indexed citations
13.
Okamoto, Kunio, Isamu Okamoto, Erina Hatashita, et al.. (2011). Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin. Molecular Cancer Therapeutics. 11(1). 204–213. 59 indexed citations
14.
Takezawa, Ken, Isamu Okamoto, Wataru Okamoto, et al.. (2011). Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. British Journal of Cancer. 104(10). 1594–1601. 145 indexed citations
15.
Tanizaki, Junko, Isamu Okamoto, Kunio Okamoto, et al.. (2011). MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations. Journal of Thoracic Oncology. 6(10). 1624–1631. 103 indexed citations
16.
Okamoto, Kunio, Isamu Okamoto, Wataru Okamoto, et al.. (2010). Role of Survivin in EGFR Inhibitor–Induced Apoptosis in Non–Small Cell Lung Cancers Positive for EGFR Mutations. Cancer Research. 70(24). 10402–10410. 75 indexed citations
17.
Takezawa, Ken, Isamu Okamoto, Junko Tanizaki, et al.. (2010). Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor Receptor. Molecular Cancer Therapeutics. 9(6). 1647–1656. 63 indexed citations
18.
Thal, Dietmar Rudolf, Sergey Larionov, Dorothée Abramowski, et al.. (2006). Amyloid beta-protein and apolipoprotein E co-localise within perivascular drainage channels in wild-type and APP-transgenic mice. Acta Neuropathologica. 112(3). 355–356. 3 indexed citations
19.
Capetillo‐Zarate, Estibaliz, M. Staufenbiel, Dorothée Abramowski, et al.. (2006). Selective vulnerability of different types of commissural neurons for amyloid  -protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology. Brain. 129(11). 2992–3005. 40 indexed citations
20.
Yamaguchi, Haruka. (1980). [Studies on the immunohistochemical localization of S-100 and glial fibrillary acidic proteins in the rat nervous system and in human brain tumors (author's transl)].. PubMed. 32(10). 1055–64. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026